By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Ataxia
  • >
  • Portage’s Biohaven orphan drug designation request granted for the treatment of spinocerebellar ataxia – PR Newswire (press release)

Portage’s Biohaven orphan drug designation request granted for the treatment of spinocerebellar ataxia – PR Newswire (press release)

Wednesday, 9 March, 2016

Portage’s Biohaven orphan drug designation request granted for the treatment of spinocerebellar ataxia – PR Newswire (press release)

Vlad Coric, M.D., CEO of Biohaven, added, "Receiving the orphan drug designation request for spinocerebellar ataxia supports our global development strategy and goal of providing improved therapies for patients suffering from neurologic disorders with ...

Read More

Source:Portage's Biohaven orphan drug designation request granted for the treatment of spinocerebellar ataxia - PR Newswire (press release)

Categories :
  • Ataxia
  • Latest Headlines
  • Uncategorized
Socials :

Recent posts

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Copyright © 2022 All rights reserved